Full Text View
Tabular View
No Study Results Posted
Related Studies
Juvenile Rheumatoid Arthritis
This study has been completed.
Study NCT00037648   Information provided by Amgen
First Received: May 17, 2002   Last Updated: February 20, 2008   History of Changes

May 17, 2002
February 20, 2008
July 2000
November 2003   (final data collection date for primary outcome measure)
The primary outcome of the study was to evaluate the safety of anakinra [ Time Frame: 28 weeks ] [ Designated as safety issue: No ]
The primary outcome of the study was to evaluate the safety of anakinra
Complete list of historical versions of study NCT00037648 on ClinicalTrials.gov Archive Site
 
 
 
Juvenile Rheumatoid Arthritis
A Randomized, Multi-Center, Blinded, Placebo-Controlled Study With an Open-Label Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHuIL-1ra (Anakinra) in Polyarticular-Course Juvenile Rheumatoid Arthritis

The purpose of this study is to determine the safety of anakinra in patients with Polyarticular-Course Juvenile Rheumatoid Arthritis, a form of rheumatoid arthritis affecting children.

 
Phase II
Interventional
Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment, Safety Study
Juvenile Chronic Arthritis
  • Drug: Anakinra
  • Drug: Placebo
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
86
November 2003
November 2003   (final data collection date for primary outcome measure)

* Male or female age 2-17 yrs inclusive * Minimum weight 10 KG * Diagnosis of Chronic Arthritis

Both
2 Years to 17 Years
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00037648
Global Development Leader, Amgen Inc.
990758-990779
Amgen
 
Study Director: MD Amgen
Amgen
February 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP